SCHEMBL19620456

SCHEMBL19620456

NC1=C(OSCc2ccccc2)C(=O)C(c2cnc3ccccc3c2)O1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 2/20 0.36
KDM4E B2RXH2 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
CFTR P13569 1/20 0.34
SLC6A4 P31645 1/20 0.34
HCRTR1 O43613 2/20 0.33
HCRTR2 O43614 2/20 0.33
MAOB P27338 2/20 0.33
KDM1A O60341 1/20 0.33
MAOA P21397 1/20 0.33
TOP2B Q02880 1/20 0.33
PDGFRB P09619 1/20 0.33
PDGFRA P16234 1/20 0.33
MGAM O43451 1/20 0.33
RAB9A P51151 1/20 0.32
ELANE P08246 2/20 0.32
DHODH Q02127 1/20 0.32
SCN9A Q15858 1/20 0.32
CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19620589 0.84 ADK (0.39) KDM4EPOLBMAPTSLC6A4MAOB
SCHEMBL19620603 0.83 POLB (0.50) KDM4EPOLBMAPTRAB9ASCN9A
SCHEMBL19620559 0.81 ALDH1A1 (0.41) KDM4EPOLBMAPTMAOBRAB9A
SCHEMBL20367966 0.80 TOP2A (0.35) TOP2AKDM4EPOLBMAPTCFTR
SCHEMBL15627553 0.80 MAPT (0.37) TOP2AKDM4EPOLBMAPTCFTR
SCHEMBL19620533 0.80 MAPT (0.42) KDM4EPOLBMAPTRAB9ACYP2C9
SCHEMBL19620689 0.79 KDM4E (0.38) KDM4EPOLBMAPTRAB9A
SCHEMBL19620654 0.79 KDM4E (0.38) KDM4EPOLBMAPT
SCHEMBL19620650 0.78 CYP19A1 (0.42) KDM4EPOLBMAPTRAB9A
SCHEMBL19620675 0.78 MAPT (0.42) KDM4EPOLBMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3345596-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2021-01-20 EP disclosed
EP-2897607-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2017-11-22 EP disclosed